Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Repasky

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Cell Cycle (Georgetown, Tex.)|July 2, 2015
A role for the thermal environment in defining co-stimulation requirements for CD4(+) T cell activationEvan R Zynda, Melissa J Grimm, Min Yuan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010Gregory B Lesinski, William E Carson, Elizabeth A Repasky, et al.
Nature Communications|March 11, 2015
Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activationJason W-L Eng, Chelsey B Reed, Kathleen M Kokolus, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 17, 2005
VSGP/F-spondin: a new ovarian cancer markerRuth A Pyle-Chenault, John A Stolk, David A Molesh, et al.
Oncogene|April 12, 2002
Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarraysYuqiu Jiang, Susan L Harlocker, David A Molesh, et al.
Plos One|March 21, 2015
Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cellsBenjamin J Povinelli, Kathleen M Kokolus, Jason W-L Eng, et al.
Scientific Reports|May 15, 2025
Chronic rejection models for vascularized composite tissue allotransplantationDaniel T Fisher, Emily Mackey, Eugene Kononov, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Prognostic immune markers in esophageal cancer patients managed with trimodal therapyMark K Farrugia, Elizabeth A Repasky, Minhui Chen, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Stimulation of an anti-tumor immune response with "chromatin-damaging" therapyMinhui Chen, Craig M Brackett, Lyudmila G Burdelya, et al.
Journal of Hepatology|August 13, 2011
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoHuanjie Shao, Chun Gao, Haikuo Tang, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Cell Cycle (Georgetown, Tex.)|July 2, 2015
A role for the thermal environment in defining co-stimulation requirements for CD4(+) T cell activationEvan R Zynda, Melissa J Grimm, Min Yuan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010Gregory B Lesinski, William E Carson, Elizabeth A Repasky, et al.
Nature Communications|March 11, 2015
Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activationJason W-L Eng, Chelsey B Reed, Kathleen M Kokolus, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 17, 2005
VSGP/F-spondin: a new ovarian cancer markerRuth A Pyle-Chenault, John A Stolk, David A Molesh, et al.
Oncogene|April 12, 2002
Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarraysYuqiu Jiang, Susan L Harlocker, David A Molesh, et al.
Plos One|March 21, 2015
Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cellsBenjamin J Povinelli, Kathleen M Kokolus, Jason W-L Eng, et al.
Scientific Reports|May 15, 2025
Chronic rejection models for vascularized composite tissue allotransplantationDaniel T Fisher, Emily Mackey, Eugene Kononov, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Prognostic immune markers in esophageal cancer patients managed with trimodal therapyMark K Farrugia, Elizabeth A Repasky, Minhui Chen, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Stimulation of an anti-tumor immune response with "chromatin-damaging" therapyMinhui Chen, Craig M Brackett, Lyudmila G Burdelya, et al.
Journal of Hepatology|August 13, 2011
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoHuanjie Shao, Chun Gao, Haikuo Tang, et al.
Pageof 15